{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:08:55Z","timestamp":1758820135852},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSPS KAKENHI Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis C virus protease (HCV-PR) and human immunodeficiency virus protease (HIV-PR) are important for virus maturation, and thus can be used as potential target molecules for the development of antiviral drugs for the treatment of viral infections. In this study, a novel assay was developed to determine HCV-PR activity. This assay is based on a fluorogenic reaction, in which peptide fragments generated from an acetyl peptide substrate by HCV-PR can be selectively converted into a fluorescent derivative, and quantified by high-performance liquid chromatography (HPLC) with fluorescent detection. Herein, several acetyl-peptides can be used as substrates for HPLC. The application of this assay was further validated by simultaneous detection of HCV-PR and HIV-PR in a reaction mixture. The proposed method can differentiate the enzyme activities of HCV-PR and HIV-PR in a sample using their corresponding substrates. The results suggest that this assay can detect various proteases by employing set of substrate peptides under the same reaction conditions.<\/jats:p>","DOI":"10.1038\/s41598-019-45711-0","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T10:03:22Z","timestamp":1561370602000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Simultaneous assay for protease activities of hepatitis C virus and human immunodeficiency virus based on fluorescence detection"],"prefix":"10.1038","volume":"9","author":[{"given":"Tsutomu","family":"Kabashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Tonooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"45711_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.2523562","volume":"244","author":"QL Choo","year":"1989","unstructured":"Choo, Q. L. et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359\u2013362 (1989).","journal-title":"Science"},{"key":"45711_CR2","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1073\/pnas.87.17.6547","volume":"87","author":"I Saito","year":"1990","unstructured":"Saito, I. et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87, 6547\u20136549 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"45711_CR3","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1086\/339042","volume":"34","author":"KE Sherman","year":"2002","unstructured":"Sherman, K. E., Rouster, S. D., Chung, R. T. & Rajicic, N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin. Infect. Dis. 34, 831\u2013837 (2002).","journal-title":"Clin. Infect. Dis."},{"key":"45711_CR4","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1128\/jvi.67.7.4017-4026.1993","volume":"67","author":"L Tomei","year":"1993","unstructured":"Tomei, L., Failla, C., Santolini, E., De, Francesco, R. & La, Monica, N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67, 4017\u20134026 (1993).","journal-title":"J. Virol."},{"key":"45711_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/abio.1996.0235","volume":"237","author":"E Bianchi","year":"1996","unstructured":"Bianchi, E. et al. Synthetic depsipeptide substrates for the assay of human hepatitis C virus protease. Anal. Biochem. 237, 239\u2013244 (1996).","journal-title":"Anal. Biochem."},{"key":"45711_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0166-0934(99)00034-8","volume":"80","author":"N Kakiuchi","year":"1999","unstructured":"Kakiuchi, N., Nishikawa, S., Hattori, M. & Shimotohno, K. A high throughput assay of the hepatitis C virus nonstructural protein 3 serine proteinase. J. Virol. Methods 80, 77\u201384 (1999).","journal-title":"J. Virol. Methods"},{"key":"45711_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1006\/abio.1997.2063","volume":"247","author":"N Takeshita","year":"1997","unstructured":"Takeshita, N. et al. An enzyme-linked immunosorbent assay for detecting proteolytic activity of hepatitis C virus proteinase. Anal. Biochem. 247, 242\u2013246 (1997).","journal-title":"Anal. Biochem."},{"key":"45711_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.peptides.2007.11.014","volume":"29","author":"T Kabashima","year":"2008","unstructured":"Kabashima, T. et al. A selective fluorescence reaction for peptides and chromatographic analysis. Peptides 29, 356\u2013363 (2008).","journal-title":"Peptides"},{"key":"45711_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ab.2009.10.030","volume":"397","author":"Z Yu","year":"2010","unstructured":"Yu, Z. et al. Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction. Anal. Biochem. 397, 197\u2013201 (2010).","journal-title":"Anal. Biochem."},{"key":"45711_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep10323","volume":"5","author":"Q Zhu","year":"2015","unstructured":"Zhu, Q. et al. Fluorometric assay for phenotypic differentiation of drug-resistant HIV mutants. Sci. Rep. 5, 10323 (2015).","journal-title":"Sci. Rep."},{"key":"45711_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ab.2012.10.018","volume":"433","author":"MS Rahman","year":"2013","unstructured":"Rahman, M. S., Kabashima, T., Yasmin, H., Shibata, T. & Kai, M. A novel fluorescence reaction for N-terminal Ser-containing peptides and its application to assay caspase activity. Anal. Biochem. 433, 79\u201385 (2013).","journal-title":"Anal. Biochem."},{"key":"45711_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1021\/jo016140o","volume":"67","author":"DJ Maly","year":"2002","unstructured":"Maly, D. J. et al. Expedient solid-phase synthesis of fluorogenic protease substrates using the 7-amino-4-carbamoylmethylcoumarin (ACC) fluorophore. J. Org. Chem. 67, 910\u2013915 (2002).","journal-title":"J. Org. Chem."},{"key":"45711_CR13","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1128\/JVI.75.19.9458-9469.2001","volume":"75","author":"ZQ Beck","year":"2001","unstructured":"Beck, Z. Q., Lin, Y. C. & Elder, J. H. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases. J. Virol. 75, 9458\u20139469 (2001).","journal-title":"J. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45711-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45711-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45711-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:43:15Z","timestamp":1671273795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45711-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["45711"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-45711-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"1 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9150"}}